ViiV to trial twice-yearly HIV antibody dosing after Phase IIb success
The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
Fierce Biotech2d
Immunocore T-cell engager clears safety hurdle, reduces HIV reservoir in some patients
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
Healio2d
Two more people potentially cured of HIV
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
US biochemist researching treatment of HIV and coronaviruses wins Israel's Wolf Prize
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
360Dx12d
Tufts Researchers Develop Paper-Based Blood Collection Device to Improve HIV Testing Accuracy
The paper-based card separates plasma from whole-blood samples, allowing them to be used for HIV viral load testing.
Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million
Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...
Giving blood linked to lower risk of pre-cancer gene
Frequent donors were more likely to have different genetic changes in their blood stem cells, scientists found.
Medscape6d
AI Tool Diagnoses Multiple Diseases From One Blood Sample
A new artificial intelligence (AI) tool can simultaneously assess blood samples for ... genes encoding immune cell receptors to identify patients with COVID-19, HIV, type 1 diabetes, lupus ...
WebMD25d
Non-Hodgkin’s Lymphoma and HIV
You might bruise or bleed easily. And if you have HIV, you'll be at an even greater risk of infection because your white blood cell count will be lower. Biologic or targeted therapy uses medicines ...